Abstract
We describe a patient with Stevens-Johnson syndrome (erythema multiforme major) associated with an increase in glipizide dosage administration. Glipizide is a second-generation sulfonylurea commonly used to treat patients with noninsulin-dependent diabetes mellitus Although several reports have documented Stevens-Johnson syndrome caused by first-generation sulfonylureas, our case appears to be the first report of a second-generation sulfonylurea associated with Stevens-Johnson syndrome.
Original language | English (US) |
---|---|
Pages (from-to) | 36-38 |
Number of pages | 3 |
Journal | Dermatitis |
Volume | 17 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2006 |
ASJC Scopus subject areas
- Immunology and Allergy
- Dermatology